ABL Bio (Korea) Today
| 298380 Stock | KRW 22,050 200.00 0.90% |
Performance2 of 100
| Odds Of DistressLess than 37
|
ABL Bio is trading at 22050.00 as of the 17th of April 2024, a -0.9 percent decrease since the beginning of the trading day. The stock's open price was 22250.0. ABL Bio has about a 37 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for ABL Bio are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of April 2023 and ending today, the 17th of April 2024. Click here to learn more.
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.. The company has 45.3 M outstanding shares. More on ABL Bio
Moving together with ABL Stock
| 0.74 | 144510 | Green Cross Lab | PairCorr |
| 0.73 | 235980 | MedPacto | PairCorr |
Moving against ABL Stock
| 0.57 | 036030 | KT Hitel | PairCorr |
| 0.51 | 293780 | AptaBio Therapeutics | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
ABL Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ABL Bio's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ABL Bio or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
ABL Bio (298380) is traded on KOSDAQ in Korea and employs 7 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 958.17 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ABL Bio's market, we take the total number of its shares issued and multiply it by ABL Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ABL Bio operates under Healthcare sector and is part of Biotechnology industry. The entity has 45.3 M outstanding shares.
ABL Bio has accumulated about 21.59 B in cash with (40.61 B) of positive cash flow from operations.
Check ABL Bio Probability Of Bankruptcy
Ownership AllocationABL Bio retains a total of 45.3 Million outstanding shares. ABL Bio retains considerable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check ABL Ownership Details
ABL Stock Price Odds Analysis
What are ABL Bio's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of ABL Bio jumping above the current price in 90 days from now is about 72.2%. The ABL Bio probability density function shows the probability of ABL Bio stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon ABL Bio has a beta of -0.2112. This suggests as returns on the benchmark increase, returns on holding ABL Bio are expected to decrease at a much lower rate. During a bear market, however, ABL Bio is likely to outperform the market. Additionally, aBL Bio has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of ABL Bio to move above the current price in 90 days from now is about 72.2 (This ABL Bio probability density function shows the probability of ABL Stock to fall within a particular range of prices over 90 days) .
ABL Bio Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. ABL Bio market risk premium is the additional return an investor will receive from holding ABL Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ABL Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although ABL Bio's alpha and beta are two of the key measurements used to evaluate ABL Bio's performance over the market, the standard measures of volatility play an important role as well.
ABL Stock Against Markets
Picking the right benchmark for ABL Bio stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ABL Bio stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ABL Bio is critical whether you are bullish or bearish towards ABL Bio at a given time. Please also check how ABL Bio's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in ABL Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
ABL Bio Corporate Management
Elected by the shareholders, the ABL Bio's board of directors comprises two types of representatives: ABL Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ABL. The board's role is to monitor ABL Bio's management team and ensure that shareholders' interests are well served. ABL Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ABL Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jung Kim | MD COO | Profile | |
| Jaecheon Lee | MD CFO | Profile | |
| Jae Jung | MD Discovery | Profile | |
| Jong Kim | MD Devel | Profile | |
| Sang Lee | Founder CEO | Profile | |
| You WeonKyoo | Head MD | Profile | |
| Jong Won | Head Devel | Profile |
How to buy ABL Stock?
Before investing in ABL Bio, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in ABL Bio. To buy ABL Bio stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of ABL Bio. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase ABL Bio stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located ABL Bio stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased ABL Bio stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as ABL Bio, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in ABL Bio?
The danger of trading ABL Bio is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of ABL Bio is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than ABL Bio. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile ABL Bio is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABL Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the ABL Bio information on this page should be used as a complementary analysis to other ABL Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for ABL Stock analysis
When running ABL Bio's price analysis, check to measure ABL Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABL Bio is operating at the current time. Most of ABL Bio's value examination focuses on studying past and present price action to predict the probability of ABL Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABL Bio's price. Additionally, you may evaluate how the addition of ABL Bio to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Correlations Find global opportunities by holding instruments from different markets |